Suppr超能文献

肝提取物-叶酸-氰钴胺素与安慰剂治疗慢性疲劳综合征的比较

Liver extract-folic acid-cyanocobalamin vs placebo for chronic fatigue syndrome.

作者信息

Kaslow J E, Rucker L, Onishi R

机构信息

Division of Basic and Clinical Immunology, University of California Irvine Medical Center, Orange 92668.

出版信息

Arch Intern Med. 1989 Nov;149(11):2501-3.

PMID:2684076
Abstract

Chronic fatigue syndrome is a recently defined entity for which clinical criteria were proposed by the Centers for Disease Control, Atlanta, Ga. A frequently advocated treatment in Southern California is an injectable solution of bovine liver extract containing folic acid and cyanocobalamin (LEFAC). We conducted a double-blind, placebo-controlled, crossover trial of intramuscular LEFAC in 15 patients who met the Centers for Disease Control criteria for chronic fatigue syndrome. Although patients responded to placebo and LEFAC by several criteria of functional status, no significant difference was apparent between response to placebo and that to LEFAC. The placebo response appeared to be strong.

摘要

慢性疲劳综合征是一种最近定义的病症,佐治亚州亚特兰大疾病控制中心为此提出了临床标准。在南加利福尼亚,一种经常被提倡的治疗方法是注射含有叶酸和氰钴胺的牛肝提取物溶液(LEFAC)。我们对15名符合疾病控制中心慢性疲劳综合征标准的患者进行了一项关于肌肉注射LEFAC的双盲、安慰剂对照交叉试验。尽管根据功能状态的几个标准,患者对安慰剂和LEFAC都有反应,但对安慰剂和LEFAC的反应之间没有明显差异。安慰剂反应似乎很强。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验